Literature DB >> 11918988

D(2) dopamine receptor (DRD2) polymorphism is associated with severity of alcohol dependence.

J P Connor1, R McD Young, B R Lawford, T L Ritchie, E P Noble.   

Abstract

The A(1) allele of the D(2) dopamine receptor (DRD2) gene has been associated with alcohol dependence. However, the expression of this allele risk on the severity of drinking behavior in patients with alcohol dependence has not been systematically explored. The present study examines the association between DRD2 A(1)(+) (A(1)/A(1) and A(1)/A(2) genotypes) and A(1)- (A(2)/A(2) genotype) allele status and key drinking parameters in alcohol-dependent patients. A sample of Caucasian adults was recruited from an alcohol detoxification unit. A clinical interview and the Alcohol Dependence Scale (ADS) questionnaire provided data on consumption, dependence, chronology of drinking and prior detoxification. A(1)(+) allele compared to A(1)- allele patients consumed higher quantities of alcohol, commenced problem drinking at an earlier age, experienced a shorter latency between first introduction to alcohol to the onset of problem drinking and had higher ADS scores. Moreover, A(1)(+) allele patients had more detoxification attempts than their A(1)- allele counterparts. In sum, alcohol-dependent patients with the DRD2 A(1) allele compared to patients without this allele are characterized by greater severity of their disorder across a range of problem drinking indices. The implications of these findings are discussed.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11918988     DOI: 10.1016/s0924-9338(02)00625-9

Source DB:  PubMed          Journal:  Eur Psychiatry        ISSN: 0924-9338            Impact factor:   5.361


  21 in total

Review 1.  Pharmacogenetic studies of alcohol self-administration and withdrawal.

Authors:  John C Crabbe; Tamara J Phillips
Journal:  Psychopharmacology (Berl)       Date:  2003-10-09       Impact factor: 4.530

2.  Genome-wide association study of alcohol dependence implicates KIAA0040 on chromosome 1q.

Authors:  Lingjun Zuo; Joel Gelernter; Clarence K Zhang; Hongyu Zhao; Lingeng Lu; Henry R Kranzler; Robert T Malison; Chiang-Shan R Li; Fei Wang; Xiang-Yang Zhang; Hong-Wen Deng; John H Krystal; Fengyu Zhang; Xingguang Luo
Journal:  Neuropsychopharmacology       Date:  2011-09-28       Impact factor: 7.853

3.  Familial risk for alcohol dependence and developmental changes in BMI: the moderating influence of addiction and obesity genes.

Authors:  Sarah D Lichenstein; Bobby L Jones; Jessica W O'Brien; Nicholas Zezza; Scott Stiffler; Brian Holmes; Shirley Y Hill
Journal:  Pharmacogenomics       Date:  2014-07       Impact factor: 2.533

4.  Hypothesizing dopaminergic genetic antecedents in schizophrenia and substance seeking behavior.

Authors:  Kenneth Blum; Marlene Oscar-Berman; Rajendra D Badgaiyan; Tomas Palomo; Mark S Gold
Journal:  Med Hypotheses       Date:  2014-02-26       Impact factor: 1.538

Review 5.  A brief, critical review of research on impaired control over alcohol use and suggestions for future studies.

Authors:  Robert F Leeman; Cheryl L Beseler; Christa M Helms; Julie A Patock-Peckham; Vanessa A Wakeling; Christopher W Kahler
Journal:  Alcohol Clin Exp Res       Date:  2013-10-07       Impact factor: 3.455

6.  Interactive association of dopamine receptor (DRD4) genotype and ADHD on alcohol expectancies in children.

Authors:  Steve S Lee; Kathryn L Humphreys
Journal:  Exp Clin Psychopharmacol       Date:  2014-03-10       Impact factor: 3.157

7.  The association between DRD2/ANKK1 and genetically informed measures of alcohol use and problems.

Authors:  Jacquelyn L Meyers; Emma Nyman; Anu Loukola; Richard J Rose; Jaakko Kaprio; Danielle M Dick
Journal:  Addict Biol       Date:  2012-09-12       Impact factor: 4.280

Review 8.  Alcohol: effects on neurobehavioral functions and the brain.

Authors:  Marlene Oscar-Berman; Ksenija Marinković
Journal:  Neuropsychol Rev       Date:  2007-09       Impact factor: 7.444

Review 9.  Neurogenetics of dopaminergic receptor supersensitivity in activation of brain reward circuitry and relapse: proposing "deprivation-amplification relapse therapy" (DART).

Authors:  Kenneth Blum; Thomas J H Chen; B William Downs; Abdalla Bowirrat; Roger L Waite; Eric R Braverman; Margaret Madigan; Marlene Oscar-Berman; Nicholas DiNubile; Eric Stice; John Giordano; Siobhan Morse; Mark Gold
Journal:  Postgrad Med       Date:  2009-11       Impact factor: 3.840

10.  Genetic susceptibility in solvent induced neurobehavioral effects.

Authors:  L Godderis; N Maertens; V de Gelder; A De Lamper; K De Ruyck; M Vernimmen; S Bulterys; G Moens; H Thierens; M K Viaene
Journal:  Neurotox Res       Date:  2009-08-22       Impact factor: 3.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.